CytoMed Therapeutics (GDTC) Operating Margin (2020 - 2025)
CytoMed Therapeutics (GDTC) operating margin from Sep 30, 2020 to Dec 31, 2025. The current CytoMed Therapeutics (GDTC) operating margin is -1388.24%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of CytoMed Therapeutics (GDTC)
| Year | Operating Margin | Change |
|---|---|---|
| 2025 | -1412.50% | -68.41% |
| 2024 | -4471.43% | +1343.31% |
| 2023 | -309.80% | -49.72% |
| 2022 | -616.22% | -57.50% |
| 2021 | -1450.00% | -56.39% |
| 2020 | -3325.00% | N/A |
Comparison CytoMed Therapeutics (GDTC) operating margin with competitors
CytoMed Therapeutics (GDTC) operating margin is -1388.24%.